Top 10 NEWStat stories of 2023

Topics that most interested NEWStat readers in the past year included stories on innovative treatments, new drug approvals, Black vet med professionals making a difference, and better understanding neurodiversity.

#10 Texas A&M testing nonsurgical alternative to treat disc herniation in dogs 

Surgery to treat herniated discs in dogs can cost up to $12,000 and result in weeks of painful recovery for the patient. A clinical trial at Texas A&M is testing a nonsurgical outpatient treatment that is far less expensive and less invasive. 


#9 Breed bans and the human-animal bond: Not taking a bite out of crime 

More than 700 cities have breed bans or restrictions to attempt to reduce dog bite injuries, but many veterinary professionals believe these types of regulations do more harm than good. 

Singler-FDA conditional approval-Epi.png

#8 FDA’s expanded conditional approval means new treatment options for cats and dogs 

The US Food and Drug Administration’s expanded conditional approval policy is meant to expedite the process for innovative and novel treatments of serious and life-threatening diseases and conditions in major species, including horses, cattle, pigs, dogs, cats, chickens, and turkeys. 

#7 8 Veterinary drugs with human health hazards 

There are more than 5,000 approved prescription and over-the-counter medications with labeled indications for veterinary patients. And a number of those products pose a health hazard to humans. 


#6 So, what’s this neurodiversity thing anyway? 

The term neurodiversity came about in the 1990s and is often used in the context of autism spectrum disorder, ADHD, dyslexia, bipolar disorder, and other neurological or developmental conditions. NEWStat contributor Wendy Ringie breaks down the idea of neurodivergence, the most common conditions, and what having a “different” brain means for you, your teammates, and your clients. 


#5 GFI 256: What FDA compounded drug guidance means for veterinary professionals 

As the FDA’s new guidance about compounded drugs (GFI-256) went into effect April 1, 2023, some substances could have become harder to get or more expensive for clients.  

10 Black Vet Med Pros-Banner-Epi.jpg.png

#4 10 Black vet med professionals to watch in 2023

Tierra Price, DVM, MPH, founder of BlackDVM Network, introduces us to 10 Black heroes of the veterinary profession who make a difference both inside and outside the veterinary practice in diverse sectors of the field ranging from academia and research to agriculture, leadership, administrative support, and media.

#3 Elanco announces first-ever canine parvovirus treatment

The USDA has granted a conditional license to the first Canine Parvovirus Monoclonal Antibody (CPMA) treatment from Elanco, which stands to be a gamechanger in fighting this deadly, highly transmissible disease.


#2 What approval for canine OA treatment Librela means for dogs (and the people who love them) 

Nearly 40% of dogs show signs of canine osteoarthritis (OA), but many don’t receive treatment. That could change with the newly FDA-approved Librela, a monthly injectable that has been used by veterinarians in Europe for the past two years with largely positive results. 


#1 New oral diabetes medication for cats requires careful consideration

Bexacat is the first oral drug treatment of diabetes in cats and offers an alternative to insulin injections but veterinarians must choose the right patients due to important safety considerations. 

Thank you for reading NEWStat! Got a great tip or story idea? Let us know at [email protected]. 

Disclaimer: The views expressed, and topics discussed, in any NEWStat column or article are intended to inform, educate, or entertain, and do not represent an official position by the American Animal Hospital Association (AAHA) or its Board of Directors.




Subscribe to NEWStat